COMPARISON OF PROGNOSTICATION BY IPSS-M, IPSS-R AND AIPSS-MDS IN THE CONTEXT OF LIMITED AVAILABILITY OF MOLECULAR DATA IN DAILY CLINICAL PRACTICE

被引:0
|
作者
Schulz, F. [1 ]
Kellersmann, C. [1 ]
Betz, B. [2 ]
Hildebrandt, B. [2 ]
Thol, F. [3 ]
Heuser, M. [3 ]
Ganster, C. [4 ]
Beier, F. [5 ]
Sockel, K. [6 ]
Hofmann, W. -K. [7 ]
Kuendgen, A. [1 ]
Pfeilstoecker, M. [8 ]
Gattermann, N. [1 ]
Nachtkamp, K. [1 ]
Haase, D. [4 ]
Germing, U. [1 ]
机构
[1] Heinrich Heine Univ Duesseldorf, Hematol Oncol & Clin Immunol, Dusseldorf, Germany
[2] Univ Klinikum Dusseldorf, Human Genet, Dusseldorf, Germany
[3] Hannover Med Sch, Hematol Hemostasis Oncol & Stem Cell Transplantat, Hannover, Germany
[4] Univ Med Gottingen, Clin Hematol & Med Oncol, Gottingen, Germany
[5] Rhein Westfal TH Aachen, Hematol Oncol Hemostaseol & Stem Cell Transplanta, Aachen, Germany
[6] Univ Hosp Carl Gustav Carus TU Dresden, Med Clin 1, Dresden, Germany
[7] Univ Klinikum Mannheim, Hematol & Oncol, Mannheim, Germany
[8] Hanusch Hosp, Oncol, Vienna, Austria
关键词
D O I
10.1016/j.leukres.2023.107225
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P090
引用
收藏
页数:2
相关论文
共 9 条
  • [1] Risk Prediction in MDS: A Validation of the IPSS-M and Comparison to IPSS-R and to Two Other Personalized Prediction Tools
    Baer, Constance
    Huber, Sandra
    Hutter, Stephan
    Meggendorfer, Manja
    Nadarajah, Niroshan
    Walter, Wencke
    Platzbecker, Uwe
    Gotze, Katharina
    Kern, Wolfgang
    Haferlach, Torsten
    Hoermann, Gregor
    Haferlach, Claudia
    BLOOD, 2022, 140 : 1128 - 1129
  • [2] Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS
    Nazha, Aziz
    Bejar, Rafael
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (05) : 461 - 467
  • [3] Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS
    Aziz Nazha
    Rafael Bejar
    Current Hematologic Malignancy Reports, 2017, 12 : 461 - 467
  • [4] A Retrospective Validation Study Comparing the IPSS-M and IPSS-R Risk Stratification Scores in Primary and Secondary Myelodysplastic Syndrome (MDS)
    Sabile, Jean M. G.
    Kaempf, Andy
    Tomic, Kaitlyn
    Manu, Gurusidda
    Swords, Ronan T.
    Migdady, Yazan
    BLOOD, 2022, 140 : 4088 - 4089
  • [5] Comparison of the Molecular International Prognostic Scoring System (IPSS-M) and Revised International Prognostic Scoring System (IPSS-R) in predicting the prognosis of patients with myelodysplastic neoplasms treated with decitabine
    Nguyen, Quang Hao
    Vu, Minh Phuong
    Tran, Tuan Anh
    Duong, Quoc Chinh
    Vu, Duc Binh
    Nguyen, Ha Thanh
    Bach, Quoc Khanh
    ONCOLOGIE, 2024, 26 (02) : 323 - 328
  • [6] Reclassification of Ascertain ( ASTX727-02) Myelodysplastic Syndrome (MDS) Patients: Outcomes Including Clinical Response, Overall Survival (OS), and Leukemia Free Survival (LFS) Based on IPSS-R and IPSS-M Scoring Systems
    Garcia-Manero, Guillermo
    McCloskey, James
    Griffiths, Elizabeth A.
    Zeidan, Amer M.
    Yee, Karen W. L.
    Al-Kali, Aref
    Deeg, H. Joachim
    Patel, Prapti A.
    Sabloff, Mitchell
    Keating, Mary-Margaret
    Zhu, Nancy
    Gabrail, Nashat Y.
    Fazal, Salman
    Maly, Joseph J.
    Odenike, Olatoyosi
    Kantarjian, Hagop M.
    DeZern, Amy E.
    O'Connell, Casey L.
    Roboz, Gail J.
    Busque, Lambert
    Buckstein, Rena
    Amin, Harsh
    Randhawa, Jasleen K.
    Leber, Brian
    Lee, Shannon
    Chan, Winny
    Souza, Sonia
    Sano, Yuri
    Keer, Harold N.
    Savona, Michael R.
    BLOOD, 2023, 142
  • [7] Evaluation of the Molecular International Prognostic Scoring System (IPSS-M) in Patients (Pts) with Myelodysplastic Syndromes/Neoplasms (MDS) with Missing Molecular Data
    Kewan, Tariq
    Bewersdorf, Jan Philipp
    Blaha, Ondrej
    Stahl, Maximilian
    Al Ali, Najla H.
    DeZern, Amy E.
    Sekeres, Mikkael A.
    Carraway, Hetty E.
    Desai, Pinkal
    Griffiths, Elizabeth A.
    Stein, Eytan M.
    Brunner, Andrew M.
    Amaya, Maria L.
    Zeidner, Joshua F.
    Savona, Michael R.
    Stempel, Jessica M.
    Chandhok, Namrata Sonia
    Logothetis, Constantine
    Cochran, Hunter
    Singh, Abhay
    Roboz, Gail J.
    Rolles, Benjamin
    Wang, Eunice S.
    Harris, Amyah C.
    Shallis, Rory M.
    Xie, Zhuoer
    Padron, Eric
    Sallman, David A.
    Maciejewski, Jaroslaw P.
    Della Porta, Matteo Giovanni
    Komrokji, Rami S.
    Zeidan, Amer M.
    BLOOD, 2023, 142
  • [8] Disease Characteristics and International Prognostic Scoring Systems (IPSS, IPSS-R, IPSS-M) in Adult Patients with Higher-Risk Myelodysplastic Syndromes (MDS) Participating in Two Randomized, Double-Blind, Placebo-Controlled Studies with Intravenous Sabatolimab Added to Hypomethylating Agents (HMA) (STIMULUS-MDS1 and MDS2)
    Santini, Valeria
    Platzbecker, Uwe
    Fenaux, Pierre
    Giagounidis, Aristoteles
    Miyazaki, Yasushi
    Sekeres, Mikkael A.
    Xiao, Zhijian
    Sanz, Guillermo
    Van Hoef, Marlies
    Ma, Fei
    Hertle, Sabine
    Ramos, Pedro Marques
    Zeidan, Amer M.
    BLOOD, 2022, 140 : 1340 - 1342
  • [9] Somatic Mutations in MDS Patients Are Associated with Clinical Features and Predict Prognosis Independent of the IPSS-R: Analysis of Combined Datasets from the International Working Group for Prognosis in MDS-Molecular Committee
    Bejar, Rafael
    Papaemmanuil, Elli
    Haferlach, Torsten
    Garcia-Manero, Guillermo
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    Walter, Matthew J.
    Graubert, Timothy A.
    Cazzola, Mario
    Malcovati, Luca
    Ogawa, Seishi
    Fenaux, Pierre
    Hellstrom-Lindberg, Eva
    Kern, Wolfgang
    Boultwood, Jacqueline
    Pellagatti, Andrea
    Bowen, David
    Tauro, Sudhir
    Groves, Michael J.
    Vyas, Paresh
    Quek, Lynn
    Nazha, Aziz
    Thol, Felicitas
    Heuser, Michael
    Shih, Lee-Yung
    Padron, Eric
    Sallman, David
    Komrokji, Rami S.
    List, Alan F.
    Santini, Valeria
    Fontenay, Michaela
    Campbell, Peter J.
    Tuechler, Heinz
    Stevenson, Kristen
    Neuberg, Donna S.
    Greenberg, Peter
    Ebert, Benjamin L.
    BLOOD, 2015, 126 (23)